Advertisement
Document › Details
CRISPR Therapeutics AG. (3/8/18). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results". Zug & Cambridge, MA.
Organisation | CRISPR Therapeutics AG (Nasdaq: CRSP) | |
Group | CRISPR Therapeutics (Group) | |
Organisation 2 | CureVac AG | |
Today | CureVac SE | |
Group | CureVac (Group) | |
Product | exagamglogene autotemcel (exa-cel) (formerly CTX001) | |
Product 2 | CTX101 (CRISPR Therapeutics) | |
Person | Kulkarni, Samarth (Sam) (CRISPR Therapeutics 201712– promoted CEO before CBO) | |
Person 2 | Paganelli, Jennifer (W2O Group 201703) | |
Original document
accessed by [iito] on 2018-03-09
Record changed: 2023-06-05 |
Advertisement
More documents for CRISPR Therapeutics (Group)
- [1] CRISPR Therapeutics AG. (2/13/24). "Press Release: European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, Casgevy (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)". Z...
- [2] CRISPR Therapeutics AG. (2/13/24). "Press Release: CRISPR Therapeutics Announces $280 Million Registered Direct Offering". Zug & Boston, MA....
- [3] CRISPR Therapeutics AG. (1/3/24). "Press Release: CRISPR Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Zug & Boston, MA....
- [4] CRISPR Therapeutics AG. (6/13/23). "Pressemitteilung: CRISPR Therapeutics to Participate in Goldman Sachs 44th Annual Global Healthcare Conference". Zug & Cambridge, MA....
- [5] CRISPR Therapeutics AG. (4/13/23). "Press Release: CRISPR Therapeutics to Participate in Needham’s 22nd Annual Healthcare Conference". Zug & Cambridge, MA....
- [6] CRISPR Therapeutics AG. (4/3/23). "Press Release: CRISPR Therapeutics and Vertex Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for Exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalas...
- [7] CRISPR Therapeutics AG. (3/29/23). "Press Release: CRISPR Therapeutics Announces Departure of Board Member". Zug & Boston, MA....
- [8] CRISPR Therapeutics AG. (3/27/23). "Press Release: CRISPR Therapeutics and Vertex Announce Licensing Agreement to Accelerate Development of Vertex’s Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes". Boston, MA & Zug....
- [9] CRISPR Therapeutics AG. (3/13/23). "Press Release: CRISPR Therapeutics Announces Transition of Chief Financial Officer". Zug & Boston, MA....
- [10] CRISPR Therapeutics AG. (2/27/23). "Press Release: CRISPR Therapeutics to Participate in the 43rd Annual Cowen Health Care Conference". Zug & Boston, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top